查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1765310

全球全EXOME定序市場

Whole Exome Sequencing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

至2030年，全球全外EXOME定序市場規模將達74億美元

全球全EXOME定序市場規模預計在2024年為24億美元，預計到2030年將達到74億美元，2024年至2030年的複合年成長率為20.2%。報告分析的細分市場之一——定序系統——預計將以21.3%的複合年成長率成長，到分析期結束時將達到41億美元。套件細分市場在分析期間的複合年成長率預計為18.3%。

美國市場規模估計為 6.773 億美元，中國市場預計複合年成長率為 18.8%

預計2024年，美國EXOME定序市場規模將達6.773億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到11億美元，在2024-2030年的分析期間內，複合年成長率為18.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為18.5%和17.1%。在歐洲，預計德國市場的複合年成長率約為14.3%。

全球全外EXOME定序市場—主要趨勢與促進因素摘要

是什麼推動了基因組研究中全EXOME定序的應用？

全EXOME定序 (WES) 因其能夠全面洞察基因組的蛋白質轉錄區（即EXOME）而在基因組研究和臨床診斷中的重要性日益凸顯。這種方法使研究人員能夠識別與疾病相關的遺傳變異，包括罕見遺傳疾病、癌症和神經系統疾病，使其成為精準醫療的有力工具。對個人化醫療的日益關注和遺傳患者病率的上升推動了 WES 在臨床和研究環境中的應用。與全基因組定序相比，WES 提供了一種經濟有效的EXOME研究方法，在了解疾病的遺傳基礎和開發標靶治療具有顯著優勢。

技術進步如何增強全EXOME定序？

次世代定序儀(NGS) 和生物資訊學技術的進步顯著提高了全EXOME定序的效率、準確性和成本效益。高通量定序平台的開發、標靶富集技術的改進以及文庫製備方法的最佳化，使得EXOME定序速度更快、更準確。生物資訊工具和軟體的創新改進了數據分析和解讀，使研究人員能夠更準確地識別臨床相關的遺傳變異。此外，人工智慧 (AI) 和機器學習 (ML) 在基因組數據分析中的融合，使得預測疾病風險、治療效果和患者預後成為可能，進一步擴展了全外顯子組在臨床診斷和精準醫療中的應用。

整個EXOME定序市場面臨哪些挑戰與機會？

全EXOME定序市場面臨許多挑戰，包括高成本、對生物資訊學專業知識的需求以及基因資料隱私方面的倫理擔憂。此外，基因變異的解讀仍然是一項重大挑戰，因為許多檢測到的變異可能具有不確定或未知的臨床意義。然而，這些挑戰也為成長和創新提供了機會。開發更具成本效益和可擴展性的定序平台以及使用者友好的生物資訊學工具，可以降低應用門檻，並擴大全外顯子定序 (WES) 在臨床環境中的應用。人們對罕見疾病研究、癌症基因組學和個人化醫療的日益關注，為WES作為識別可操作基因變異的關鍵工具提供了新的成長機會。此外，協作研究網路和基因組資料庫的興起，推動了對能夠與現有醫療保健和研究基礎設施整合的強大、可互通的定序解決方案的需求。

是什麼推動了整個EXOME定序市場的成長？

整個EXOME定序市場的成長受到多種因素的推動，包括對個人化醫療的日益關注、遺傳病患病率的上升以及次世代定序儀和生物資訊學的技術進步。需要全面的基因組學見解來識別致病突變並開發標靶治療，這極大地推動了臨床和研究環境中對 WES 的市場需求。高通量測序、靶向序列捕獲和人工智慧主導的數據分析的技術創新使 WES 更加高效、準確和具有成本效益，從而使更廣泛的醫療保健提供者和研究人員更容易獲得它。隨著相關人員尋求強大的基因組工具來進行疾病診斷、風險評估和治療開發，精準醫療計劃的不斷發展以及對罕見疾病研究和腫瘤學的日益關注也在推動市場發展。

部分

產品（系統、套件、服務）；應用（診斷、藥物發現與開發、個人化醫療、其他應用）

受訪公司範例

  • Agilent Technologies, Inc.
  • Ambry Genetics
  • BGI Europe
  • Eurofins Genomics GmbH
  • GENEWIZ, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • Roche Nimblegen, Inc.
  • Sengenics
  • Thermo Fisher Scientific, Inc.

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP15631

Global Whole Exome Sequencing Market to Reach US$7.4 Billion by 2030

The global market for Whole Exome Sequencing estimated at US$2.4 Billion in the year 2024, is expected to reach US$7.4 Billion by 2030, growing at a CAGR of 20.2% over the analysis period 2024-2030. Systems, one of the segments analyzed in the report, is expected to record a 21.3% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Kits segment is estimated at 18.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$677.3 Million While China is Forecast to Grow at 18.8% CAGR

The Whole Exome Sequencing market in the U.S. is estimated at US$677.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 18.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.5% and 17.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.3% CAGR.

Global Whole Exome Sequencing Market - Key Trends & Drivers Summarized

What Is Driving the Adoption of Whole Exome Sequencing in Genomic Research?

Whole exome sequencing (WES) is rapidly gaining importance in genomic research and clinical diagnostics due to its ability to provide comprehensive insights into the protein-coding regions of the genome, known as exomes. This method enables researchers to identify genetic variants associated with diseases, including rare genetic disorders, cancers, and neurological conditions, making it a powerful tool for precision medicine. The increasing focus on personalized medicine and the rising prevalence of genetic diseases are driving the adoption of WES in clinical and research settings. Compared to whole-genome sequencing, WES offers a cost-effective approach to studying the exome, providing significant advantages in understanding the genetic basis of diseases and developing targeted therapies.

How Are Technological Advancements Enhancing Whole Exome Sequencing?

Technological advancements in next-generation sequencing (NGS) and bioinformatics are significantly enhancing the efficiency, accuracy, and cost-effectiveness of whole exome sequencing. The development of high-throughput sequencing platforms, improved target enrichment techniques, and optimized library preparation methods are enabling faster and more accurate sequencing of the exome. Innovations in bioinformatics tools and software are improving data analysis and interpretation, allowing researchers to identify clinically relevant genetic variants with greater precision. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) in genomic data analysis is enabling the prediction of disease risk, treatment response, and patient outcomes, further expanding the application of WES in clinical diagnostics and precision medicine.

What Are the Challenges and Opportunities in the Whole Exome Sequencing Market?

The whole exome sequencing market faces several challenges, including the high cost of sequencing, the need for specialized bioinformatics expertise, and ethical concerns related to genetic data privacy. Additionally, the interpretation of genetic variants remains a significant challenge, as many detected variants may have uncertain or unknown clinical significance. However, these challenges also present opportunities for growth and innovation. The development of more cost-effective and scalable sequencing platforms, along with user-friendly bioinformatics tools, can help lower the barriers to adoption and expand the use of WES in clinical practice. The increasing emphasis on rare disease research, cancer genomics, and personalized medicine is creating new growth opportunities for WES as a critical tool for identifying actionable genetic variants. Moreover, the rise of collaborative research networks and genomic databases is driving the need for robust and interoperable sequencing solutions that can integrate with existing healthcare and research infrastructures.

What Is Driving the Growth of the Whole Exome Sequencing Market?

The growth in the Whole Exome Sequencing market is driven by several factors, including the increasing focus on personalized medicine, rising prevalence of genetic disorders, and technological advancements in next-generation sequencing and bioinformatics. The need for comprehensive genomic insights to identify disease-causing variants and develop targeted therapies is significantly boosting market demand for WES in clinical and research settings. Technological innovations in high-throughput sequencing, target enrichment, and AI-driven data analysis are enhancing the efficiency, accuracy, and cost-effectiveness of WES, making it more accessible to a broader range of healthcare providers and researchers. The expansion of precision medicine initiatives, coupled with the growing emphasis on rare disease research and oncology, is also driving market growth as stakeholders seek powerful genomic tools for disease diagnosis, risk assessment, and therapeutic development.

SCOPE OF STUDY:

The report analyzes the Whole Exome Sequencing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Systems, Kits, Services); Application (Diagnostics, Drug Discovery & Development, Personalized Medicine, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Agilent Technologies, Inc.
  • Ambry Genetics
  • BGI Europe
  • Eurofins Genomics GmbH
  • GENEWIZ, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • Roche Nimblegen, Inc.
  • Sengenics
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Whole Exome Sequencing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Genetic Research Propel the Use of Whole Exome Sequencing
    • Rising Prevalence of Genetic Disorders Amplifies Demand for Whole Exome Sequencing
    • Cost Reduction in Sequencing Technologies Spurs Whole Exome Sequencing Adoption
    • Clinical Applications in Personalized Medicine Enhance Whole Exome Sequencing Capabilities
    • Pharmaceutical Companies Increasing Investment in Drug Discovery Supports Market Growth
    • Consumer Interest in Ancestry and Genealogy Expands Market Reach
    • Expansion of Newborn Screening Programs Drives Whole Exome Sequencing Services
    • Research and Development in Rare Diseases Bolster Use of Exome Sequencing
    • Growing Biobanking Activities Sustain Demand for Whole Exome Sequencing
    • Integration of AI and Machine Learning in Genomic Research Transforms Market Landscape
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Whole Exome Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Personalized Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • CHINA
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 30: China Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: China 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 32: China Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: Europe 6-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Europe 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 40: France Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: France 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 42: France Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: France 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Germany 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Italy 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Italy 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 52: UK Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: UK 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 54: UK Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: UK 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Rest of World 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Rest of World 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030

IV. COMPETITION